INTRODUCTION
Vitamin D deficiency is pandemic and is present in more than one billion people all over the world. 1 The occurrence of vitamin D deficiency/ insufficiency is high not only in countries where sunlight is less but as well in countries near equator because of their traditional and religious clothing habits and life style.
2 Most of the persons with vitamin D deficiency/insufficiency are asymptomatic and hence making diagnosis of Vitamin D deficiency is very challenging. Vitamin 25(OH) D levels less than 20 ng/ml are taken as cut off for vitamin D deficiency. 3 Hypovitaminosis D has been associated with various diseases including hypertension, cardiovascular diseases (CVD), type-1 and type-2 diabetes mellitus (DM), obesity, dyslipidemia, congestive heart failure, multiple
Special Communication
Use of Oral Vitamin-D Glass ampoule and tablet:
Experience of patients and physicians , we were unable to find any evidence about the experiences, concern and preferences of both practices among patients as well as health care physicians. This survey was designed to find the common experiences about orally administered glass ampoules and oral tablets of Vitamin D in our population and the general perception regarding its safety and hazards.
METHODS
This cross sectional survey was conducted from November 1 st 2016 to 15 th December 2016 in different outpatient department of different hospitals in Karachi, Lahore and Islamabad. Patients who were prescribed Vitamin D glass ampoule from oral route in last three months were included along with physicians who routinely prescribe vitamin D after taking informed consent. The participants were asked about injuries related to the use of glass ampoule, ease of using this form, after taste preference of tablet or injectable form as well as demography. Response rate for patients was 60.2% while for doctors was 80%. Data was analyzed with SPSS version 24.0.
RESULTS
Total of 182 patients and 96 doctors who fulfilled the inclusion criteria were included in the study. Out of 182 patients, 61.5 (%) were male while 38.5 1 Dosing is either 25,000 IU every fortnight for 8 weeks (total dose 100,000 IU), 25,000 IU every week for 6 weeks (total dose 150,000 IU), or 25 000 IU every week for 8 weeks (total dose 200,000 IU). 10 There are over 100 different labels available for Vitamin D in Pakistan. On average, Oral chewable are slightly expensive than oral liquid form.
Opening ampoules is a particularly highrisk event. Sharps injuries (SIs) were caused by opening an ampoule.
11 Most frequently reported circumstances of sharps injuries were opening of ampoules and vials, 12 which may result in compliance issue with Vitamin D ampoules. In our study 33% patients had some cut injury while opening the ampoule, of which 5.7% required bandaging. Another risk associated with glass ampoules is particle contamination.
13
Recent estimates for noncompliance vary from study to study and ranges from 62 to 84 percent using electronic monitoring. 14, 15 Hence, it is very important for physician to eliminate all possible factors that might influence patient compliance. In our study only 32.6% (n=52) felt comfortable breaking the glass ampoules and rest relied on other to break the ampoule. Patients who are active participants in a shared decision-making process have a better knowledge of treatment options and more realistic perceptions of likely treatment effects. The resulting treatment choices are more likely to concur with their preferences and attitudes to risk. 16 Only 47.5% (n=85) patients said that their doctor took consent Syed Umair Maroof et al. for giving them Vitamin D in oral liquid ampoule. Physicians are inclined to prescribe oral liquid form as they believe its bioavailability is higher; however there is no clinical data available for comparison of bioavailability of both forms. It is well established that actively engaged patients are also more likely to adhere to treatment recommendations. 16 In our study, only 39.7% (n=71) patients said that their physician demonstrated them how to break a glass ampoule. About 46.9% (n=45) doctors said that they teach their patients how to break ampoule. Few pharmacies of hospitals also train patient how to break a glass ampoule but the practice is very rare in Pakistan health care system. Oral liquid medications with poor palatability may lead to non-compliance. 17 In our study 49.4% of patients experience bad taste after taking vitamin D from glass ampoule. About 74% physicians believe that compliance of patient on vitamin D tablets is better than patients on oral liquid form.
It is empirical that doctors should take consent from patients before prescribing any form of vitamin D and take into consideration the hazard related to oral vitamin D in glass ampules. Proper training to break ampoule must be given to patients to combat their fear and reluctance to break glass ampoule. However, it is better if physicians prescribe tablets of Vitamin D if available.
Limitations of the Study: Despite providing some useful information, this study has certain limitations. Firstly only a small number of patients were enrolled in the study. There is a need for much larger multi-centre study to confirm our findings.
